AbbVie Inc. ( ABBV ) will begin trading ex-dividend on July 12, 2019. A cash dividend payment of $1.07 per share is scheduled to be paid on August 15, 2019. Shareholders who purchased ABBV prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that ABBV has paid the same dividend. At the current stock price of $71.65, the dividend yield is 5.97%.
The previous trading day's last sale of ABBV was $71.65, representing a -28.51% decrease from the 52 week high of $100.23 and a 10.14% increase over the 52 week low of $65.06.
ABBV is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and Pfizer, Inc. ( PFE ). ABBV's current earnings per share, an indicator of a company's profitability, is $3.49. Zacks Investment Research reports ABBV's forecasted earnings growth in 2019 as 10.96%, compared to an industry average of -2.7%.
Interested in gaining exposure to ABBV through an Exchange Traded Fund [ETF]?
The following ETF(s) have ABBV as a top-10 holding:
- AdvisorShares Vice ETF ( ACT )
- Invesco Exchange-Traded Fund Trust II Invesco S&P Ultra Divide ( RDIV )
- Invesco Dynamic Pharmaceuticals ETF ( PJP )
- First Trust Morningstar ETF ( FDL )
- Goldman Sachs Access Investment Grade Corporate Bond ETF ( GIGB ).
The top-performing ETF of this group is FDL with an increase of 6.79% over the last 100 days. ACT has the highest percent weighting of ABBV at 5.21%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.